Satti Zahir, Omari Muntaser, Bawamia Bilal, Cartlidge Timothy, Egred Mohaned, Farag Mohamed, Alkhalil Mohammad
Cardiothoracic Department, Freeman Hospital, Freeman Road, Newcastle upon Tyne NE7 7DN, UK.
Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.
J Clin Med. 2024 Apr 15;13(8):2291. doi: 10.3390/jcm13082291.
Optimal myocardial reperfusion during primary percutaneous coronary intervention (pPCI) is increasingly recognized to be beyond restoring epicardial coronary flow. Both invasive and non-invasive tools have highlighted the limitation of using this metric, and more efforts are focused towards achieving optimal reperfusion at the level of the microcirculation. Recent data highlighted the close relationship between thrombus burden and impaired microcirculation in patients presenting with ST-segment elevation myocardial infarction (STEMI). Moreover, distal embolization was an independent predictor of mortality in patients with STEMI. Likewise, the development of no-reflow phenomenon has been directly linked with worse clinical outcomes. Adjunctive thrombus aspiration during pPCI is intuitively intended to remove atherothrombotic material to mitigate the risk of distal embolization and the no-reflow phenomenon (NRP). However, prior trials on the use of thrombectomy during pPCI did not support its routine use, with comparable clinical endpoints to patients who underwent PCI alone. This article aims to review the existing literature highlighting the limitation on the use of thrombectomy and provide future insights into trials investigating the role of thrombectomy in contemporary pPCI.
在直接经皮冠状动脉介入治疗(pPCI)期间,最佳心肌再灌注越来越被认为不仅仅是恢复心外膜冠状动脉血流。侵入性和非侵入性工具都凸显了使用这一指标的局限性,并且更多努力集中在实现微循环水平的最佳再灌注上。最近的数据突出了ST段抬高型心肌梗死(STEMI)患者血栓负荷与微循环受损之间的密切关系。此外,远端栓塞是STEMI患者死亡率的独立预测因素。同样,无复流现象的发生与更差的临床结局直接相关。pPCI期间的辅助血栓抽吸直观上旨在清除动脉粥样硬化血栓物质,以降低远端栓塞和无复流现象(NRP)的风险。然而,先前关于pPCI期间使用血栓切除术的试验并不支持其常规使用,其临床终点与单纯接受PCI的患者相当。本文旨在回顾现有文献,突出血栓切除术使用的局限性,并为研究血栓切除术在当代pPCI中的作用的试验提供未来见解。